{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/whitlow-staphylococcal-herpetic/","result":{"data":{"firstChapter":{"id":"8442fc1d-a788-50ac-a15a-9c2c91e8589b","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 91a2e84b-5dbf-44dc-a014-a0c11a93b90c --><h1>Whitlow (staphylococcal and herpetic): summary</h1><!-- end field 91a2e84b-5dbf-44dc-a014-a0c11a93b90c -->","htmlStringContent":"<!-- begin item c510fdf9-d19c-4ff9-81af-9f90f9615cba --><!-- begin field 74e5f060-91a4-448a-ac55-22db8fb6dd0b --><ul><li>Staphylococcal whitlow (also known as a felon) is a closed-space infection of the distal finger pulp.<ul><li>It presents with a rapid onset of very severe, throbbing pain, with redness and swelling of the distal pulp of the finger tip. There is usually a history of a penetrating injury or untreated paronychia. Fluctuance and pointing of an abscess may be present.</li></ul></li><li>Herpetic whitlow is a herpes simplex infection that typically appears on the distal phalanx of the fingers.              <ul><li>It often presents with abrupt onset of oedema, redness, and localized severe tenderness of the infected finger. The pulp space is soft, not tensely swollen, and vesicles are present. There may be a history of current or recent herpetic lesions in the mouth or genitals, or a history of fever or malaise preceding the onset of symptoms.</li></ul></li><li>Conditions which may present in a similar way to whitlow include cellulitis, paronychia, osteomyelitis, and cancer (for example melanoma or squamous cell carcinoma).</li><li>Swabs may be useful in some cases, but are not always required.</li><li>For the management of tense or fluctuant staphylococcal whitlows, same-day incision and drainage should be considered.</li><li>For staphylococcal whitlows that do not require incision and drainage, treatment includes:<ul><li>Giving advice on elevating the finger as much as possible, applying moist heat 3-4 times a day to hasten drainage of pus, and taking paracetamol or ibuprofen for pain relief.</li><li>Considering antibiotic treatment with flucloxacillin, or, if the person is allergic to penicillin, erythromycin, or clarithromycin.</li><li>Seeking specialist advice if the person is known to have MRSA infection.</li></ul></li><li>For treatment of a herpetic whitlow:<ul><li>Incision and drainage is not recommended.</li><li>An antiviral drug such as aciclovir should be considered if the person presents within 48 hours of the onset of symptoms.</li><li>The person should be advised to avoid touching the affected finger, to cover it with a dressing, and to take paracetamol or ibuprofen as required for pain relief.</li></ul></li></ul><!-- end field 74e5f060-91a4-448a-ac55-22db8fb6dd0b --><!-- end item c510fdf9-d19c-4ff9-81af-9f90f9615cba -->","topic":{"id":"ac1c1826-f21a-5abd-8e92-1e2db8ea28ea","topicId":"f989f159-ab30-4d16-b9df-b534a9fd4192","topicName":"Whitlow (staphylococcal and herpetic)","slug":"whitlow-staphylococcal-herpetic","aliases":["Staphylococcal whitlow - and herpetic","Herpetic whitlow - and staphylococcal"],"chapters":[{"id":"8442fc1d-a788-50ac-a15a-9c2c91e8589b","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"895f3b40-8720-5843-8910-fe1b288857a8","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7e4ec3c7-b080-5717-b1c3-0003acba46e5","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"7c70fe97-728d-5bc4-94c2-1996b37ee0f9","slug":"changes","fullItemName":"Changes"},{"id":"4889bd92-0b32-558d-8390-80d27fbcce73","slug":"update","fullItemName":"Update"}]},{"id":"1a79ca57-c8cc-5044-ac68-5d220bab1460","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"684fde23-e839-56ff-8b7f-8e6863b2c42d","slug":"goals","fullItemName":"Goals"},{"id":"97b35971-df6d-5ecb-a631-dfcf580e1fa9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12181a78-1b8d-58b4-884a-8930d15cf654","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"521ae353-eea7-5e2f-bd0e-b292540b72eb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"87054726-2905-5ac0-b369-92e5fd68a177","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2b6dffce-588f-532a-9776-7e3ff32005ee","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"2d957194-aa56-5cb7-98aa-cb3d8f988743","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"f0191f08-fb2e-5c5b-957c-8a190d5b4539","slug":"definition","fullItemName":"Definition"},{"id":"b8b2a1f1-fbc7-5b8f-a5c4-c0e9409d566f","slug":"causes","fullItemName":"Causes"},{"id":"c7287d38-e377-5d65-9c4f-3201369e0213","slug":"prevalence","fullItemName":"Prevalence"},{"id":"adc749af-b4d0-50c9-9996-b470b8f76613","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d632b72f-6e73-58ee-9d8d-21b6101f6394","slug":"prognosis","fullItemName":"Prognosis"},{"id":"faed0075-1878-5f17-abc9-9316eaa064e7","slug":"complications","fullItemName":"Complications"}]},{"id":"96e4a200-e348-5fab-89e2-f0ba789b7b72","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"910097a7-71be-5c13-949e-0be7c045df35","slug":"diagnosis-of-whitlow","fullItemName":"Diagnosis of whitlow"},{"id":"6f468174-fafe-579c-90f9-500f22e70e17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"8ac8a269-e748-5e7e-9b74-8fb5661d1ae5","slug":"management","fullItemName":"Management","subChapters":[{"id":"ac7fabf7-d7b7-5fb2-a0a6-1d28e040e2c8","slug":"staphylococcal-whitlow","fullItemName":"Scenario: Staphylococcal whitlow"},{"id":"bde8ed40-6fd8-505e-86bb-d75eac34743f","slug":"herpetic-whitlow","fullItemName":"Scenario: Herpetic whitlow"}]},{"id":"5d7afad5-ae43-5c2e-8ecf-6df00603ca01","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"ae3b006b-c4df-5e15-aee8-5ac6c019923f","slug":"aciclovir","fullItemName":"Aciclovir"},{"id":"46185de6-35ef-5e34-a1fd-e0d1463c538e","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"2a50e932-9f92-5a94-a8e5-aab1ee400b9d","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"0ad07f56-519a-59d6-90bc-6b6d6081e6ab","slug":"flucloxacillin","fullItemName":"Flucloxacillin"}]},{"id":"98ea0d83-9b18-58b4-aa73-7a50d72e15ba","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"4dd77db6-a4e1-5304-8a06-196e7628f612","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"0191f79d-0e03-554c-b0bd-4b592d452f4a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3e95c155-472c-52d0-9098-a797cec2ad27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f39c5716-7472-576a-be8f-7d705a0dc4dd","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"73c24405-a40a-51ba-ac01-8dd957f7c657","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7005b3b9-63e2-5222-840e-73155dac338e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"18dd81bb-78d7-57f1-9fc9-24aa775b3c9d","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"ac1c1826-f21a-5abd-8e92-1e2db8ea28ea","topicId":"f989f159-ab30-4d16-b9df-b534a9fd4192","topicName":"Whitlow (staphylococcal and herpetic)","slug":"whitlow-staphylococcal-herpetic","aliases":["Staphylococcal whitlow - and herpetic","Herpetic whitlow - and staphylococcal"],"topicSummary":"Staphylococcal whitlow is a closed-space infection of the distal finger pulp.","lastRevised":"Last revised in January 2021","nextPlannedReviewBy":"2021-04-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2021-03","nextPlannedReviewByDisplay":"March 2021","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"8442fc1d-a788-50ac-a15a-9c2c91e8589b","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"895f3b40-8720-5843-8910-fe1b288857a8","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7e4ec3c7-b080-5717-b1c3-0003acba46e5","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"7c70fe97-728d-5bc4-94c2-1996b37ee0f9","slug":"changes","fullItemName":"Changes"},{"id":"4889bd92-0b32-558d-8390-80d27fbcce73","slug":"update","fullItemName":"Update"}]},{"id":"1a79ca57-c8cc-5044-ac68-5d220bab1460","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"684fde23-e839-56ff-8b7f-8e6863b2c42d","slug":"goals","fullItemName":"Goals"},{"id":"97b35971-df6d-5ecb-a631-dfcf580e1fa9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12181a78-1b8d-58b4-884a-8930d15cf654","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"521ae353-eea7-5e2f-bd0e-b292540b72eb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"87054726-2905-5ac0-b369-92e5fd68a177","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2b6dffce-588f-532a-9776-7e3ff32005ee","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"2d957194-aa56-5cb7-98aa-cb3d8f988743","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"f0191f08-fb2e-5c5b-957c-8a190d5b4539","slug":"definition","fullItemName":"Definition"},{"id":"b8b2a1f1-fbc7-5b8f-a5c4-c0e9409d566f","slug":"causes","fullItemName":"Causes"},{"id":"c7287d38-e377-5d65-9c4f-3201369e0213","slug":"prevalence","fullItemName":"Prevalence"},{"id":"adc749af-b4d0-50c9-9996-b470b8f76613","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d632b72f-6e73-58ee-9d8d-21b6101f6394","slug":"prognosis","fullItemName":"Prognosis"},{"id":"faed0075-1878-5f17-abc9-9316eaa064e7","slug":"complications","fullItemName":"Complications"}]},{"id":"96e4a200-e348-5fab-89e2-f0ba789b7b72","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"910097a7-71be-5c13-949e-0be7c045df35","slug":"diagnosis-of-whitlow","fullItemName":"Diagnosis of whitlow"},{"id":"6f468174-fafe-579c-90f9-500f22e70e17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"8ac8a269-e748-5e7e-9b74-8fb5661d1ae5","slug":"management","fullItemName":"Management","subChapters":[{"id":"ac7fabf7-d7b7-5fb2-a0a6-1d28e040e2c8","slug":"staphylococcal-whitlow","fullItemName":"Scenario: Staphylococcal whitlow"},{"id":"bde8ed40-6fd8-505e-86bb-d75eac34743f","slug":"herpetic-whitlow","fullItemName":"Scenario: Herpetic whitlow"}]},{"id":"5d7afad5-ae43-5c2e-8ecf-6df00603ca01","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"ae3b006b-c4df-5e15-aee8-5ac6c019923f","slug":"aciclovir","fullItemName":"Aciclovir"},{"id":"46185de6-35ef-5e34-a1fd-e0d1463c538e","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"2a50e932-9f92-5a94-a8e5-aab1ee400b9d","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"0ad07f56-519a-59d6-90bc-6b6d6081e6ab","slug":"flucloxacillin","fullItemName":"Flucloxacillin"}]},{"id":"98ea0d83-9b18-58b4-aa73-7a50d72e15ba","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"4dd77db6-a4e1-5304-8a06-196e7628f612","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"0191f79d-0e03-554c-b0bd-4b592d452f4a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3e95c155-472c-52d0-9098-a797cec2ad27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f39c5716-7472-576a-be8f-7d705a0dc4dd","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"73c24405-a40a-51ba-ac01-8dd957f7c657","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7005b3b9-63e2-5222-840e-73155dac338e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"18dd81bb-78d7-57f1-9fc9-24aa775b3c9d","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"ac1c1826-f21a-5abd-8e92-1e2db8ea28ea"}},"staticQueryHashes":["3666801979"]}